Research output: Contribution to journal › Article › peer-review
50Scopus
citations
Fingerprint
Dive into the research topics of 'Phase i study of the mTOR inhibitor ridaforolimus and the HDAC inhibitor vorinostat in advanced renal cell carcinoma and other solid tumors'. Together they form a unique fingerprint.